Publish
Home
Live
new
RH Journal
ResearchCoin
Grants
Funding
Browse
Journals
Hubs
Tools
Lab Notebook
Beta
Reference Manager
Resources
Verify Identity
Community
Support
About
Terms
Privacy
Issues
Docs
Paper
Log in
Sign up
Paper
0
Paper
Conversation
Grants
Reviews
Document
Download
Flag content
0
Orally Bioavailable CDK9 Inhibitor Voruciclib Downregulates Oncogenic Pathways in Leukemic Cells from Patients Treated on a Clinical Trial
Genetics
Oncology
Pharmacology
Show More
Authors
Edward Dominguez
,
Carly Roleder
Canping Chen
,
Zheng Xia
,
Sandra Wiley
,
Matthew Davids
+4 authors
,
Alexey Danilov
Journal
Blood
Published
Nov 5, 2024
DOI
10.1182/blood-2024-198693
Show more
Save
Tip
Document
Download
Flag content
0
Tip
Save
Document
Download
Flag content
Paper
Conversation
Grants
Reviews
TipTipTipTip